» Authors » M Tramontana

M Tramontana

Explore the profile of M Tramontana including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 92
Citations 496
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stingeni L, Antonelli E, Caroppo E, Ferrucci S, Ortoncelli M, Fabbrocini G, et al.
J Eur Acad Dermatol Venereol . 2022 Apr; 36(8):1292-1299. PMID: 35412683
Background: Moderate-to-severe atopic dermatitis (AD) in the adolescence is a high burden disease, and its treatment can be very challenging due to paucity of approved systemic drugs for this age...
2.
Stingeni L, Marietti R, Tramontana M, Bianchi L, Hansel K
J Eur Acad Dermatol Venereol . 2022 Feb; 36(3):326-327. PMID: 35174911
No abstract available.
3.
Hansel K, Biondi F, Bianchi L, Tramontana M, Marietti R, Stingeni L
Clin Exp Dermatol . 2021 Jun; 46(8):1603-1606. PMID: 34184292
No abstract available.
4.
Tramontana M, Hansel K, Bianchi L, Marietti R, Stingeni L
J Eur Acad Dermatol Venereol . 2021 Jun; 35(11):e765-e767. PMID: 34062011
No abstract available.
5.
Tramontana M, Hansel K, Bianchi L, Agostinelli D, Stingeni L
J Eur Acad Dermatol Venereol . 2020 Jan; 34(5):e223-e225. PMID: 31904884
No abstract available.
6.
Stingeni L, Tramontana M, Principato M, Moretta I, Principato S, Bianchi L, et al.
Br J Dermatol . 2019 Sep; 182(2):498-500. PMID: 31535362
No abstract available.
7.
Masini P, Zampetti S, Minon Llera G, Biancolini F, Moretta I, Romani R, et al.
J Eur Acad Dermatol Venereol . 2019 Aug; 34(1):e28-e30. PMID: 31419365
No abstract available.
8.
Stingeni L, Tramontana M, Principato M, Moretta I, Principato S, Bianchi L, et al.
J Eur Acad Dermatol Venereol . 2019 Aug; 34(1):e25-e27. PMID: 31419335
No abstract available.
9.
Bianchi L, Tramontana M, Biondi F, Hansel K, Gallina L, Scagliarini A, et al.
Br J Dermatol . 2019 Mar; 180(3):e67. PMID: 30821380
No abstract available.
10.
Bellucci F, Bueno L, Bugianesi R, Crea A, DAranno V, Meini S, et al.
Br J Pharmacol . 2016 Jan; 173(8):1329-38. PMID: 26758701
Background And Purpose: The tachykinin NK2 receptor antagonist ibodutant is under Phase III clinical investigation to treat female patients with irritable bowel syndrome. The aim of this study was to...